SCHEMBL28567423

SCHEMBL28567423

COCCOC1CN(c2ccc3c(n2)CC[C@H](NC(=O)OCc2ccccc2)C3)CC1NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
ACHE P22303 2/20 0.43
RORC P51449 5/20 0.37
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
CTSK P43235 1/20 0.37
PDE4B Q07343 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TACR1 P25103 2/20 0.36
PDE10A Q9Y233 2/20 0.36
MEN1 O00255 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
CPB1 P15086 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28567425 1.00 CA1 (0.43) CA1CA2ACHERORCCTSL
SCHEMBL20722877 0.92 CA1 (0.46) CA1CA2ACHERORCCTSL
SCHEMBL20722500 0.90 MAP4K4 (0.36) PDE10ACKS1BSKP1SKP2
SCHEMBL28567921 0.88 CA1 (0.45) CA1CA2ACHERORCCTSL
SCHEMBL28567919 0.88 CA1 (0.45) CA1CA2ACHERORCCTSL
SCHEMBL30968500 0.88 CA1 (0.45) CA1CA2ACHERORCCTSL
SCHEMBL20722776 0.88 CA1 (0.45) CA1CA2ACHERORCCTSL
SCHEMBL23938263 0.85 CA1 (0.44) CA1CA2ACHERORCCTSL
SCHEMBL30968421 0.85 CA1 (0.44) CA1CA2ACHERORCCTSL
SCHEMBL28572866 0.85 CA1 (0.44) CA1CA2ACHERORCCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112867712-B Carboxamide as ubiquitin-specific protease inhibitor 瓦洛早期发现股份有限公司 2024-07-16 CN disclosed
CN-112867712-A Carboxamides as ubiquitin-specific protease inhibitors 瓦洛早期发现股份有限公司 2021-05-28 CN disclosed